Exact Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Exact Sciences 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About EXAS

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. 

CEO
Kevin T. Conroy
CEOKevin T. Conroy
Employees
7,000
Employees7,000
Headquarters
Madison, Wisconsin
HeadquartersMadison, Wisconsin
Founded
1995
Founded1995
Employees
7,000
Employees7,000

EXAS Key Statistics

Market cap
19.55B
Market cap19.55B
Price-Earnings ratio
-19.26
Price-Earnings ratio-19.26
Dividend yield
Dividend yield
Average volume
2.42M
Average volume2.42M
High today
$102.46
High today$102.46
Low today
$102.21
Low today$102.21
Open price
$102.32
Open price$102.32
Volume
1.60M
Volume1.60M
52 Week high
$102.66
52 Week high$102.66
52 Week low
$38.81
52 Week low$38.81

Stock Snapshot

With a market cap of 19.55B, Exact Sciences(EXAS) trades at $102.43. The stock has a price-to-earnings ratio of -19.26.

On 2026-01-19, Exact Sciences(EXAS) stock moved within a range of $102.21 to $102.46. With shares now at $102.43, the stock is trading +0.2% above its intraday low and -0.0% below the session's peak.

Trading volume for Exact Sciences(EXAS) stock has reached 1.6M, versus its average volume of 2.42M.

The stock's 52-week range extends from a low of $38.81 to a high of $102.66.

The stock's 52-week range extends from a low of $38.81 to a high of $102.66.

Analyst ratings

81%

of 26 ratings
Buy
19.2%
Hold
80.8%
Sell
0%

People also own

Based on the portfolios of people who own EXAS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .